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Bacteria use type III secretion systems (TTSS) to
translocate effector proteins into host cells. Better
understanding of the TTSS and its effectors’ func-
tions will require assays to measure their activities
in vivo and in real time. We designed a real-time,
high-throughput translocation assay that utilizes fu-
sions of effector genes to the b-lactamase reporter
gene, positioned under the effector’s native pro-
moter and chromosomal location. Using this assay,
we simultaneously and quantitatively analyzed the
translocation kinetics of six core enteropathogenic
E. coli effectors, EspF, EspG, EspH, EspZ, Map,
and Tir. A distinct order in the efficiencies of effector
translocation was observed. Translocation efficiency
was determined by multiple factors, including the
intrabacterial effector concentration, effector-chap-
erone interactions, the efficiency of bacterial attach-
ment to the host cells, and possibly also by a translo-
cation autoinhibition mechanism. The described
real-time translocation assay could be easily adap-
ted for varied applications in the study of bacterial
pathogenesis.
INTRODUCTION
The type III secretion system (TTSS) is used by pathogenic bac-
teria, including enteropathogenic E. coli (EPEC), to inject (trans-
locate) effector proteins into eukaryotic host cells. The translo-
cated effectors subvert normal host cell functions to the benefit
of the bacteria (Chen and Frankel, 2005). Upon attachment,
EPEC delivers a battery of effectors, including Tir, which is in-
serted into the host cell membrane and forms a binding site for
the bacterial outer membrane protein intimin. Subsequent Tir-in-
timin interactions trigger the formation of actin structures, termed
‘‘actin pedestals.’’ Other translocated effectors of EPEC include
Map, EspH, EspF, EspG, and EspZ, which constitute the ‘‘core
effectors’’ common to EPEC and related pathogens and are en-
coded within a pathogenicity island termed the locus of entero-
cyte effacement (LEE). These pathogens encode also less con-
served non-LEE effectors that interfere with diverse cell
functions (Dahan et al., 2005; Kanack et al., 2005; Kenny et al.,104 Cell Host & Microbe 3, 104–113, February 2008 ª2008 Elsevie2002; Li et al., 2006; Matsuzawa et al., 2005; McNamara et al.,
2001; Mundy et al., 2004; Tobe et al., 2006; Tomson et al.,
2005; Tu et al., 2003).
A typical effector contains two regions required for its translo-
cation: the N-terminal signal domain (NSD) and the chaperone-
binding domain (CBD) (Gauthier and Finlay, 2003; Ghosh,
2004; Ramamurthi and Schneewind, 2003). The NSD, spanning
residues 1–20, is sufficient for effector secretion (to the me-
dium) and translocation (into host cells) when the effector is over-
expressed, as demonstrated for Cif, Map, Tir, EspF, and EspZ
(Charpentier and Oswald, 2004; Crawford and Kaper, 2002; Ka-
nack et al., 2005). The CBD, typically located between residues
20–100, is involved in effector-chaperone interactions, which
are required for efficient translocation. Chaperones promote
translocation by stabilizing the effectors, maintaining them in
a secretion-competent conformation, and by targeting the
bound effector to the TTSS (summarized in Ghosh, 2004). Two
effector chaperones have been identified in EPEC. CesF, which
binds to EspF and enhances its translocation (Elliott et al., 2002),
and CesT, which binds and enhances the translocation of Tir
and Map (Abe et al., 1999; Creasey et al., 2003; Elliott et al.,
1999) and probably also influences the translocation of EspH,
EspZ, and some non-LEE effectors (Thomas et al., 2005).
The functions of effectors within the host cell appear to be co-
ordinated. In EPEC, for example, Tir, Map, and EspH collaborate
to organize the assembly and disassembly of actin filopodia and
pedestals (Kenny et al., 2002; Tu et al., 2003). Concerted func-
tion of effector proteins was described also in other pathogens
that use TTSSs including Yersinia, Salmonella, and Shigella
(Galan and Wolf-Watz, 2006; Kubori and Galan, 2003; Parsot,
2005). It has been proposed that different efficiencies of effector
targeting to the TTSS, leading to a hierarchy in effector translo-
cation, might be one of the mechanisms to coordinate effector
function (Ghosh, 2004; Tu et al., 2003).
In this study, we examined the hypothesis that effectors are
translocated in a hierarchical fashion and researched the param-
eters defining this hierarchy. We carried out real time, popula-
tion-based, translocation kinetic assays, analyzing simulta-
neously the translocation of EspF, EspG, EspH, EspZ, Tir, and
Map. We noted differences between the effectors in transloca-
tion rates, resulting in a translocation hierarchy. Translocation ef-
ficiency was affected by several parameters, including the effi-
ciency of bacterial attachment to host cells, the effectors’
concentrations in the bacteria, their interaction with chaperones,
and possibly also by an autoinhibitory process.r Inc.
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Construction of EPEC Strains Containing Chromosomal
effector-blaM Fusions
To analyze the translocation of effectors, we fused the blaM
(b-lactamase) reporter gene (Charpentier and Oswald, 2004)
with the LEE encoded effector genes espF, espG, espH, espZ,
map, and tir, such that each chimeric fusion protein was posi-
tioned at the effector’s native chromosomal location under the
control of the native promoter. To generate these recombinant
strains, we constructed a suitable suicide vector (pCX391) and
used it as described in Figure 1A. In the case of tir, map, and
espZ, the native as well as the blaM fused alleles were ex-
pressed from the native promoters, while in the case of espF,
espG, and espH, the blaM-fused alleles were expressed from
the native promoter, but the native alleles were promoterless
and, thus,werenotexpressed (Figure1A,andFigureS1Aavailable
online).
Effector-BlaM Fusion Concentrations
in the Infecting EPEC
The strains containing effector-blaM fusions exhibited growth
rates similar to that of the wild-type strain (data not shown).
Western blot analysis using anti-BlaM antibody verified that the
Effector-BlaM fusions were of the expected sizes (data not
shown). For Tir, western blot analysis using anti-Tir antibodies
confirmed that this fusion was expressed at a similar level to
the corresponding native protein (Figure S1B). Importantly, it
was established that the Effector-BlaM fusions were expressed
in a manner typical of LEE genes, repressed strongly when
grown in LB, and activated upon growth in CDMEM (Figures
1B and 1C). To confirm that all the Effector-BlaM fusions have
similar specific activity, we compared the levels of their enzy-
matic activity with that of their amounts determined by western
analysis using anti-BlaM antibody. Our results indicate that the
enzymatic activity faithfully reflects the amount of the corre-
sponding Effector-BlaM fusion proteins (Figures 1C and 1D). Us-
ing the activity of defined concentrations of purified BlaM as a
reference, we estimated the average concentration and number
of molecules per bacterium for each of the Effector-BlaM fusions
(Figure 1D and the Supplemental Data available online). We
found that intrabacterial effector concentrations differ by more
then an order of magnitude, ranging from 0.3 mM (for EspH-
BlaM) to 5.0 mM (for Tir-BlaM).
Effector-BlaM Fusions Expressed from Single Copy
Chromosomal Genes Are Translocated Effectively
and Detectably
The assay we designed to evaluate the translocation of effector-
blaM fusions into HeLa cells is based onmonitoring CCF2, which
is a fluorescent substrate of BlaM (as described in Figure S2).
Two features of our assay system were checked before begin-
ning our experiments. First we confirmed that expression of ef-
fector-blaM fusions does not affect EPEC-host cell interactions.
Indeed, strains expressing effectors-blaM fusions attached to
HeLa cells and formed actin pedestals with efficiencies compa-
rable to wild-type EPEC strains (Figure S1C and data not shown).
Second, we validated that the recombinant strains are indeed
capable of translocating Effector-BlaM fusions into HeLa cellsCelland/or secreting them into the medium. HeLa cells were loaded
with CCF2 and infected with each of the different strains. At
80 min postinfection, the cells were washed and the amount of
CCF2 cleavage product in the cells (reflecting the presence of
BlaM fusion in the infected cells’ cytoplasm) and BlaM activity
in the medium (reflecting the amount of secreted BlaM fusion)
were determined (Figures 1E and 1F). A strain containing a plas-
mid expressing EspB-BlaM was used as a control for these as-
says. EspB, a translocon component, is mainly secreted to the
medium and to a lesser extent is translocated into the host cell
membrane and cytoplasm (Wolff et al., 1998). We observed
negligible secretion of BlaM fusions, excluding EspB-BlaM,
(Figure 1E and Figures S4 and S5) and efficient translocation of
all fusions into infected cells, though the amounts translocated
varied (Figure 1F). These results prove that our assay to monitor
translocation is sensitive and is capable of detecting the translo-
cation of effectors that are expressed from natively controlled
single copy genes.
Real-Time Translocation Analysis
The strains expressing blaM fusions were used to determine the
relative translocation kinetics of the different effectors; the assay
was as follows. HeLa cells, seeded in 96-well plates, were pre-
loaded with CCF2 and then infected with a fixed amount of bac-
teria expressing an effector-blaM fusion (Supplemental Data).
Infection was executed within a plate reader machine preset
to 37C, enabling real-time monitoring of CCF2 hydrolysis
throughout the infection process. This real-time translocation
assay was designed so that the accumulation rate of the
CCF2 hydrolysis product reflects the concentration of effector
in the infected HeLa cells (see details in the Experimental Proce-
dures and Supplemental Data). We found that each Effector-
BlaM fusion exhibited distinct kinetics of product accumulation
(Figure 2A). However, in all cases, after an initial burst of effector
translocation, the rate of product accumulation became con-
stant, indicating that the cytoplasmic level of effector reached
a steady state (Figure 2A). Moreover, using an alternative ap-
proach, we confirmed that also translocated native Tir reaches
a steady state at 40 min postinfection (Figure 2B). At later
time points, CCF2 depletion resulted in a reduced ability to
faithfully monitor Effector-BlaM levels in infected HeLa cells
(Figure S7). The high reproducibility of this assay was ascer-
tained by comparing replicate translocation experiments
(Figure 2C).
Effector-BlaM Fusion Concentrations
in Infected Host Cells
The steady state (maximal) concentration of effector in the HeLa
cells (represented by the even slopes and indicated by stars in
Figure 2A) was estimated based on the translocation kinetic
data (as described in the Supplemental Data). BlaM follows sim-
ple Michaelis-Menten enzymatic kinetics (Zlokarnik, 2000), and
its Kcat and Km to CCF2 were determined (29 1/s and 23 mM re-
spectively) (Zlokarnik, 2000). Given the reaction velocity (rate of
product accumulation) and substrate concentration ([CCF2]),
the BlaM concentration ([E]) in the host cell was calculated as de-
scribed (Supplemental Data) and indicated in brackets within
Figure 2A.Host & Microbe 3, 104–113, February 2008 ª2008 Elsevier Inc. 105
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Hierarchy in Effector TranslocationFigure 1. The Translocation Monitoring System
(A) Formation of chromosomal blaM fusions. The example shown is pCX442,
a suicide plasmid encoding the LEE5 promoter (PLEE5) and tir translationally
fused to blaM. Upon its integration into the chromosome via homologous re-
combination, both tir and tir-blaM are placed under native regulation (see
also Figure S1A).
(B and C) Strains carrying the effector-blaM fusions, as well as a strain that
does not carry any fusion (WT), were grown under LEE-repressing conditions
(LB, shaking at 37C to density of OD600 0.2) (B) or LEE-inducing conditions
(CDMEM, static at 37C, to density of OD6000.2) (C). Bacterial proteins were
extracted and specific b-lactamase activity was determined (a typical experi-
ment out of three independent experiments is shown).106 Cell Host & Microbe 3, 104–113, February 2008 ª2008 ElsevieHierarchy of Translocation Efficiencies
The data support a direct correlation between translocation effi-
ciency, maximal effector concentration in the HeLa cells, and the
timing with which an effector is first detected within the infected
cells. Translocated Tir-BlaMwas the first to be detected and had
the highest steady-state level, suggesting that it is injected most
efficiently (Figures 2A and 2B). In contrast, translocated
Map-BlaM was barely detectable at 40 min postinfection and
had the lowest steady-state level at 60 min postinfection
(Figure 2A), indicating that it is translocated inefficiently. The
translocation efficiencies of the other effectors fall between Tir
and Map to give the following hierarchy, Tir > EspZ > EspF >
EspH > EspG > Map (Figure 2A). A similar hierarchy in effector
translocation efficiencies was evident when we used Caco2, in-
stead of HeLa, as host cells (Figure S8B). In conclusion, our data
reveal that the TTSS delivers effectors at different efficiencies,
leading to a translocation hierarchy.
The Bacterial Effector Concentration Influences
the Translocation Hierarchy
The translocation efficiencies, except that of EspH, correlate di-
rectly with the effectors’ concentrations in the bacteria (com-
pare Figures 1C, 1D, and 2A). This suggests that the effector
concentration in the bacteria is important in determining its
translocation efficiency. To test this prediction, we compared
the translocation efficiency of strains expressing native Effec-
tor-BlaM levels with strains expressing increased Effector-
BlaM levels from an ectopic promoter (the basal activity of the
tac promoter and a medium copy number plasmid were used).
The strains containing plasmids encoding effector-blaM grew
similarly to wild-type EPEC and did not secrete the expressed
BlaM fusion excessively (data not shown and Figure S5). In-
creasing the expression of EspF, EspG, EspH, and Map en-
hanced their translocation rate (Figure 3). However, EspZ over-
expression did not affect its translocation efficiency, and Tir
translocation was slightly reduced upon its overexpression.
These results indicate that in most cases the concentration of
the effector in the bacterial cell influences its translocation
efficiency and that in these cases reprogramming of the
(D) The protein samples from (C) were subjected to western blot analysis using
anti-BlaM antibody (upper panel). A nonspecific band was used as an internal
control (middle panel). The intrabacterium concentration of each Effector-
BlaM fusion (lower panel) was estimated as described in the Supplemental
Data.
(E and F) Strains carrying the chromosomally located effector-blaM fusions,
a strain expressing EspB-BlaM from a plasmid (pEspB), and a strain that
does not carry any fusions (negative control), were grown in LEE-inducing con-
ditions and used to infect CCF2 preloaded HeLa cells. To enable normalization
of the data, initial CCF2 levels in loaded HeLa cells were quantified before in-
fection (excitation at 405 nm, emission measured at 535 nm; termed loading
efficiency). After 80 min of infection, the supernatant was recovered and
cleared. b-lactamase activity in the cleared media, reflecting secreted Effec-
tor-BlaM levels, was determined using nitrocefin as substrate (E). After remov-
ing the supernatant, b-lactamase activity retained in the HeLa cells was quan-
tified by measuring the amount of CCF2 cleavage product (excitation at
405 nm, emission measured at 465 nm). This reflects translocated Effector-
BlaM levels. Results were normalized using the loading efficiency (F). Each col-
umn in (E) and (F) is the average value of three independent assays. The bars
represent the standard error of the mean.r Inc.
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intrabacterial effector concentration.
CesT and CesF Play a Role in Establishing
the Translocation Hierarchy
The native intrabacterial concentrations of Tir and EspZ are
higher than those of the other effectors, but their translocation
was not enhanced upon further increases in their concentration
(Figures 1C and 3). These observations suggest that another fac-
Figure 2. Hierarchy in Effector Translocation
(A) The EPEC strains, each containing a different chromosomally encoded ef-
fector-blaM gene, were subjected to real-time translocation analysis as de-
scribed in the Experimental Procedures. The results of a typical experiment
are shown. EPEC that do not carry an effector-blaM fusion were used as a neg-
ative control. For each fusion, a constant rate of product accumulation (de-
noted by an asterisk) is taken to represent the steady state level of BlaM.
We deduced the number of Effector-BlaM molecules per HeLa cell at steady
state levels as described in the Supplemental Data. The values are estimates,
since under our experimental conditions the enzymatic reaction catalyzed by
BlaM reaches only 70%–85% of Vmax (see Supplemental Data for details). The
values are in brackets at the right side of each curve.
(B) HeLa cells were infected with wild-type EPEC, and at different time points
(as indicated), the HeLa cells were washed and harvested. HeLa cells proteins
were extracted and analyzed by western blotting using anti-Tir antibodies. Un-
der our extraction conditions, the bacteria remain intact and the only proteins
extracted are derived from the HeLa cell membrane or cytoplasm. Arrows are
used to indicate translocated Tir, the two bands presumably representing
phosphorylated and unphosphorylated forms, while an arrowhead points to
a nonspecific protein band. As a negative control, HeLa cells were infected
with EPEC Dtir. As in (A), Tir reached a steady-state level around 40 min post-
infection.
(C) Two experiments assaying the translocation rate of Tir-BlaM were carried
out on different days and compared (blue dots). A least-squares trend line de-
scribing the comparison was generated using Excel (red line and equation).Celltor, such as chaperons, limits Tir and EspZ translocation. There-
fore, we tested the chaperons influence on the translocation ef-
ficiency of the six effector-BlaM fusions. Both cesT and cesF
were inactivated and the chromosomal effector-blaM fusions
were constructed within these mutants. In the absence of
CesF, translocation of EspF was reduced to background levels,
while the other five effectors were translocated at wild-type
levels (Figure 4A). In the absence of CesT, translocation of
Map, EspH, and EspZ was abolished completely, translocation
of Tir was delayed and reduced, but the translocation efficien-
cies of EspF and EspG were unaffected (Figure 4B). These re-
sults substantiate previous reports that CesT and CesF play
a critical role in regulating the translocation efficiency of different
effectors. In particular, the data confirm that CesT is required for
the translocation of EspH and EspZ. The latter was not shown
directly before, but was expected, as CesT is required for the se-
cretion of these effectors to the medium (Thomas et al., 2005).
In summary, these results show that the chaperones play a criti-
cal role in the determination of the translocation efficiency and
hierarchy.
The dependency of EspH translocation on CesT suggests that
they should interact. We found that, indeed, CesT binds EspH
(Figure 4C and data not shown). We next tested the affect of
Figure 3. The Effect of Intrabacterial Effector-BlaM Concentrations
on Translocation Efficiency
Strains in which the effector-blaM gene was either a chromosomal single-copy
gene (green line) or encoded on amulticopy plasmid (blue line) were subjected
to real time translocation analysis. A strain that does not carry an effector-blaM
fusion was used as the negative control (red line). The fused effectors are in-
dicated in the graphs. The insets show western analysis using anti-BlaM anti-
body of the Effector-BlaM level in infecting bacteria: on the left, the fusion was
in a chromosomal location, and on the right, it was plasmid encoded. Note that
it is not possible to compare different Effector-BlaM levels between insets as
each blot was developed for different periods as required.Host & Microbe 3, 104–113, February 2008 ª2008 Elsevier Inc. 107
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Regulate Translocation
(A and B). The translocation efficiencies exhibited
by wild-type EPEC (blue line) were compared to
those of mutant EPEC strains (green line): DcesF::
kan (A) or DcesT::kan (B). The different strains car-
rying chromosomal effector-blaM fusions were
subjected to real-time translocation analysis; typ-
ical experiments are shown. The fused effectors
are indicated within each graph. A wild-type
EPEC strain that does not carry an effector-blaM
fusion was used as a negative control (red line).
Note that blue and green overlap for Map and
EspG in (A), and red and green overlap for EspF
in (A) and for Map, EspH, and EspZ in (B).
(C) CesT binds to EspH. Extracts were derived
from E. coli K-12 expressing EspH-Flag or 6His-
CesT. The 6His-CesT extract was passed through
a metal affinity chromatography column, unbound
proteins were washed away, and then the EspH-
Flag containing extract was passed over the
same column. After thorough washing of the col-
umn, column-bound proteins were eluted and an-
alyzed by western using anti-6His and anti-EspH
antibodies (lane 4), in parallel with the original
EspH-Flag (lane 1) and 6His-CesT (lane 2) ex-
tracts. As a control, an additional binding assay
was performed, but the order of extract loading
was reversed (lane 3). The lack of any column-
bound proteins in this control assay confirms
that retention of EspH-Flag on the column is
CesT-dependent. The antibodies used are indi-
cated on the left-hand side, and on the right
side, arrows point to the EspH-Flag and 6His-
CesT proteins. Molecular weights markers are
noted on the left (lane M).
(D) CesT stabilizes native Tir, Map, and EspH, but
not EspF. Proteins were extracted from an EPEC
DcesT::kan mutant, wild-type EPEC, or wild-type
EPEC containing a plasmid encoding cesT
(pME19) and, thus, overexpressing cesT. The ex-
tracts were analyzed by western blotting with anti-
bodies against Tir, Map, EspH, or EspF. Native
EspH could be detected in the bacteria only
upon cesT overexpression.the CesT presence on the intrabacterial concentrations of CesT-
effectors partners (e.g., EspH, Tir, and Map) and other effectors
(EspF). In wild-type EPEC, we could detect (using immunoblot
with specific antibodies) the presence of Tir, Map, and EspF,
but not that of EspH. EspH could be clearly detected, however,
upon cesT overexpression (Figure 4D) Thus, CesT probably sta-
bilizes EspH within the EPEC cytoplasm. Furthermore, upon
cesT inactivation, we noticed a clear decrease in Tir and Map
concentration (Figure 4D), confirming previous reports (Abe
et al., 1999; Creasey et al., 2003; Elliott et al., 1999). We did
not test for CesT-EspZ interaction, but we predict that they inter-
act and that CesT stabilizes EspZ as well. In conclusion, these
results highlight the chaperone’s dual role in regulating translo-
cation efficiency: (1) they affect the steady-state level of the ef-
fectors in the bacteria cytoplasm by stabilizing them, and (2)
the chaperones direct the effectors to the TTSS delivery cham-
ber (Gauthier and Finlay, 2003).108 Cell Host & Microbe 3, 104–113, February 2008 ª2008 ElsevierTranslocated BlaM Fused to the LEE Effectors
Are Stable
Our results indicate that the effectors reach steady-state levels
at 30–60 min postinfection (Figures 2A and 2B), but the bacte-
ria continue to attach to the host cells after 60 min (Figure S11C).
These observations indicate that the contribution of ‘‘early-
attaching’’ EPEC to the effectors’ concentrations in the HeLa
cells is greater than that of ‘‘late-attaching’’ bacteria. A possible
explanation for this phenomenon is that the rate of effector deg-
radation increases during infection, and at some point, the rate of
effector translocation equals that of effector degradation in the
HeLa cells so as to achieve a steady-state level. We do not favor
this mechanism in light of our finding that (1) translocated Tir is
stable, (2) translocation of the six Effector-BlaM fusions is not af-
fected by proteasome inhibition, and (3) the six Effector-BlaM fu-
sions are stable in the host cell (Supplemental Data and Figures
S9A, S9B, S9C, and S9D).Inc.
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An alternative scenario is that the steady-state levels are
achieved because the early-attaching EPEC produce a signal
that reduces the capacity of the late-attaching EPEC to perform
protein translocation (termed ‘‘autoinhibition’’). To test this pos-
sibility we adopted a two-step infection protocol (that serves as
an ‘‘autoinhibition assay’’). CCF2 loaded HeLa cells were in-
fected for 30 min with a ‘‘first wave’’ of EPEC (not expressing
any Effector-BlaM fusions), and the cells were then washed
and infected with a ‘‘second wave’’ of EPEC-expressing tir-
blaM (Figure 5A). Translocation by the second wave was in-
hibited by the first wave in a first wave- and multiplicity of infec-
tion (moi)-dependent manner (Figure 5A). Similar results were
obtained for the other 5 BlaM fusions (Figure S10). Importantly,
when an EPEC escV mutant (carrying a nonfunctional TTSS)
was used as a first infection wave, translocation autoinhibition
of the second wave was not observed (Figure 5B and Fig-
ure S10). This indicates that autoinhibition is TTSS-dependent.
Microscopic examination indicated that at these mois, both
wild-type EPEC and the escV mutant attach to the host cells
with similar efficiency, covering very limited regions of the host
cells’ surfaces (Figure 5C). Thus, it is not likely that autoinhibition
is due to simple masking of the host cells’ surfaces by the first
wave bacteria. Therefore, we surmise that early-attaching EPEC
change the host cells, somehow making them less susceptible
to further protein translocation.
The translocation assay used in this study reflects both the
rate of bacterial attachment to the host cells as well as the rate
of effector translocation (Figure S11). Accordingly, mutants defi-
cient in bundle forming pili (BFP) biogenesis are attenuated in
both attachment to host cell and translocation. (Nougayrede
et al., 2003; Figure S11). Thus, we examined whether transloca-
tion autoinhibition is mediated by inhibition of BFP-mediated at-
tachment. We reasoned that if the translocation autoinhibition
reflects inhibition of BFP-mediated attachment, translocation
by a bfpA mutant should not be subject to translocation autoin-
hibition. In contrast, we found that the bfpAmutant was still sub-
jected to translocation autoinhibition (Figure 5D), excluding the
possibility that translocation autoinhibition is due to inhibited
BFP-mediated attachment.
Formation of Actin Pedestals Is Subjected
to Autoinhibition
The formation of actin pedestals in the host cells is dependent on
Tir translocation and, thus, can be used as an indicator of protein
translocation. Therefore, we employed the two-wave infection
protocol described above, but translocation was evaluated by
inspecting actin pedestals in the host cells. Note that we used
a bfpA mutant containing a GFP-expressing plasmid (pSA11)
for the second wave, as bfpAmutants formmore distinct pedes-
tals that are easier to quantify, and the GFP enables visualization
of these bacteria and distinguishes them from the first wave bac-
teria. HeLa cells remained uninfected or were infected for 30 min
with a first wave of either wild-type EPEC or escV mutant. The
cells were then washed and infected for 60 min with a second
wave of EPEC bfpAmutant expressing gfp. Samples were fixed
and actin filaments were stained with phalloidin-rhodamine. In
the experiments where either escV mutants or no bacteria
were used for the first wave, most second wave bfpA bacteriaCel(GFP tagged) formed robust actin pedestals (Figures 6A and
6B), confirming the absence of autoinhibition. When wild-type
EPEC bacteria were used for the first wave, the second wave
bfpA bacteria rarely exhibited accompanying actin pedestals
Figure 5. Translocation Autoinhibition
(A and B). HeLa cells were infected with wild-type EPEC (A) or escVmutant (B)
at the indicated MOI (‘‘first wave’’). At 30 min postinoculation, cells were
washed to remove unattached bacteria and infected at a fixed moi (1500)
with wild-type EPEC containing a chromosomal tir-blaM fusion (‘‘second
wave’’). The translocation of Tir-BlaM by the second wave bacteria was mon-
itored using the real-time translocation assay (blue and green lines). The
strains used for the first and second infection wave are indicated as ‘‘first/
second’’. As a positive control, cells were infected only with wild-type EPEC
containing a chromosomal tir-blaM fusion (i.e., no first wave; turquoise line)
and as a negative control, cells were infected only with wild-type EPEC that
did not carry an effector-blaM gene (i.e., no second wave; red line).
(C) Wild-type EPEC or an escVmutant was used to infect HeLa cells at a moi of
10,000 (‘‘first wave’’). After 30 min, the cells were washed, fixed, and visual-
ized. Typical fields are shown. Typical EPEC microcolonies and vacant HeLa
cell membrane areas are indicated by arrow heads and stars, respectively.
(D) HeLa cells were infected with wild-type EPEC (blue line) or an escVmutant
(green line) at a moi of 2500 (‘‘first wave’’). At 30 min postinfection, cells were
washed to remove unattached bacteria and infected at a fixed MOI (1500)
with a bfpA mutant containing a chromosomal espF-blaM fusion (second
wave). The translocation of EspF-BlaM by the second wave bacteria wasmon-
itored using the real time translocation assay. As a positive control, cells were
infected only with wild-type EPEC containing a chromosomal espF-blaM fu-
sion (i.e., no first wave; turquoise line) and as a negative control cells were in-
fected only with wild-type EPEC that did not carry an effector-blaM gene (i.e.,
no second wave; red line). Using other mois for the first infection wave yielded
similar results (data not shown).l Host & Microbe 3, 104–113, February 2008 ª2008 Elsevier Inc. 109
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was shorter and thinner (data not shown), indicating that the
phenomenon of autoinhibition was occurring. These results sup-
port the hypothesis that the translocation process is subject to
autoinhibition.
DISCUSSION
Hierarchies in TTSS Assembly
and Effector Translocation
Hierarchy is a recurring characteristic of the mechanisms under-
lying TTSS function. First, TTSS assembly involves ordered de-
livery of the different building blocks that form the needle com-
plex. Several aspects of this hierarchical process have been
investigated and described (Cornelis, 2006; Marlovits et al.,
2006). Second, upon bacterial engagement of the host cell,
the TTSS is activated to insert, into the host cell membrane,
the translocator proteins that form the translocation pore, an-
other hierarchical process. Subsequently the TTSS switches to
effector-injection mode, which is an enigmatic phenomenon
(Deng et al., 2005). Finally, as we describe here, there are hier-
archical differences in the efficiency of effector delivery by the
TTSS.
Single-Cell, Real-Time Translocation Analysis
Two groups describe the use of advancedmicroscopy for single-
cell, real-time analysis of the translocation process. Enninga
et al. (2005) used semipermeabilized Shigella cells in conjunction
with plasmid-expressed FlAsH-labeled translocators (IpaB and
IpaC) to monitor TTSS activity. Schlumberger et al. (2005) ex-
ploited the association of Salmonella SipA effector with a host
GFP-labeled chaperone to achieve real-time imaging. In both
systems, translocation rates varied considerably between differ-
ent bacterium, but a constant feature was that translocation
(Schlumberger et al., 2005), or effector release (Enninga et al.,
2005), began within 1 min of bacterial docking to the host cell
surface and was completed within 2–10 min. Although these
methods enable analysis of translocation at the single-cell level,
they have the consequent disadvantages of being technically110 Cell Host & Microbe 3, 104–113, February 2008 ª2008 Elsevier Inchallenging and difficult to automate for simultaneous analysis
and comparison of large numbers of effectors.
Population-Based, Real-Time Translocation Analysis
The goal of this study was to test the hypothesis that effector
translocation is hierarchical and to define the parameters deter-
mining the order of translocation efficiencies. Since EPEC can
deliver20 effectors, single-cell analysis was not a practical ap-
proach for determining translocation order. Therefore we devel-
oped a real-time, population-based translocation assay that
makes use of the blaM reporter gene and its FRET substrate
CCF2. Other population-based translocation assays, including
those that relay on the cyaA gene and short ELK tag (Boland
et al., 1996; Garcia et al., 2006), were also considered. These
technologies are very reliable, but employing them for high-
throughput and real-time analysis is difficult due to the need to
extract the infected cells for each time point, followed by deter-
mination of cAMP levels, or phosphorylated ELK tag in the cell
extracts (Boland et al., 1996; Garcia et al., 2006). In contrast,
the blaM-based technology is relatively easy to automate and
to scale-up for high throughput, as we exemplify by the simulta-
neous analysis of six blaM fusion strains. We found the BlaM as-
say to be also reproducible and sensitive. In the population-
based assays, the average translocation efficiency is quantified
from a large population of bacterial and host cells, and conse-
quently, the values are more reliable than those generated by
single-cell analysis. Nevertheless, some questions, such as
whether there are distinct subpopulations within a culture, can
be better addressed by single-cell analysis. We anticipate that
developing the blaM reporter system for microscopy-based,
single-cell analysis should be straightforward and will prove
useful.
Comparison between the Results Obtained by Single-
Cell and Population-Based Translocation Analyses
In single-cell translocation analysis, T0 is when the bacterium at-
taches to the host cell, whereas in our study, T0 is at inoculation.
Therefore, translocation efficiency is a composite of both attach-
ment and translocation rates. Thus, comparison of translocation
Figure 6. The Formation of Actin Pedestals Can Be Used as
a Measure of Translocation and Its Autoinhibition
HeLa cells grown on coverslips were infected at a moi of 850 for 30 min
with wild-type EPEC or escV mutant (first wave). The HeLa cells were
washed to remove unattached EPEC and infected for an hour with the
EPEC bfpAmutant containing a plasmid expressing GFP (pSA11; second
wave). As a control, HeLa cells were infected only with the EPEC bfpAmu-
tant expressing GFP (i.e., no first wave). Infected HeLa cells were washed,
fixed, and stained with tagged phalloidin to visualize cellular actin. Micros-
copy was used to quantify pedestal formation induced by attached bfpA
mutants and is given as a percentage, n > 114 (the bars represent stan-
dard error of the mean) (A). Phase-contrast (upper) and fluorescent (lower)
images of typical microscopy samples are shown in (B). The second wave
bfpA bacteria appear green, whereas HeLa cell actin is labeled red. Ar-
rows point to GFP-expressing bacteria, which form actin pedestal while
arrowheads point to GFP-expressing bacteria that fail to induce the for-
mation of actin pedestals (all panels). Crosses mark escV bacteria (do
not express GFP) that fail to induce the formation of actin pedestals (mid-
dle panels). Stars mark wild-type bacteria (do not express GFP) that in-
duce the formation of pedestals (right panels).c.
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we used the population-based, real-time assay with high moi
to reduce the time gap between inoculation and attachment,
we could detect translocation of Tir-BlaM within 10 min, indicat-
ing that some bacteria translocated Tir-BlaM in less than 10 min.
This translocation time is comparable to that determined by sin-
gle-cell analysis (2–10 min). Differences in the biology of the
pathogens under study may also contribute to the variations in
translocation efficiency detected by single-cell versus popula-
tion-based analyses: Shigella and Salmonella, which were
used in the single-cell studies, are equipped with100 ‘‘regular’’
TTSSs, while EPEC, which was used in this study, possesses
only 10 TTSSs fitted with an EspA extension filament (Daniell
et al., 2001). Direct comparison between the different pathogens
using the same assay is required to address whether bacterial
type is a parameter that introduces biological variability.
Parameters that Determine Translocation Efficiency
The first parameter is intrabacterial effector concentration, which
in turn reflects a balance between transcription and stability. As
shown in this report, intrabacterial effector stability is increased
upon interaction with chaperons. Previous studies indicate an
additional and unusual role of chaperons in influencing effector
concentration and, thus, translocation order, which involves
transcription modulation. In Shigella, the IpgC chaperon is a co-
activator of MxiE, an AraC-like positive regulator. It is proposed
that initially IpgC aids the translocation of early effectors and
later binds to MxiE to facilitate the expression and subsequent
translocation of late effectors (Mavris et al., 2002). A similar biol-
ogy has been suggested for the Salmonella SicA chaperon and
InvF positive regulator (Darwin and Miller, 2001).
In addition to stabilizing effectors, and rare cases of transcrip-
tional control, the chaperons were reported to guide effectors to
the TTSS, helping them to compete with one another for the
translocation channel (Boyd et al., 2000; Gauthier and Finlay,
2003). However, in EPEC, most of the effectors are relayed to
the TTSS on the same chaperon, CesT, and thus, the competi-
tion might be at the level of binding to CesT. In this context,
the case of EspH is particularly interesting. We noted that
EspH was translocated more efficiently than Map or EspG
(Figure 2A) despite their higher concentration in the bacteria (Fig-
ures 1C and 1D). Furthermore, we suggest that the affinity of
EspH for CesT is relatively low, which would explain EspH insta-
bility and low steady-state levels in the bacteria. Indeed, overex-
pressed CesT was found to stabilize EspH and caused a dra-
matic increase in EspH intrabacterial level. We propose that
the particularly efficient targeting of EspH to the TTSS is due to
its N-terminal signal domain (NSD), which somehow compen-
sates for low EspH concentration. Notably, in the bfpA back-
ground, the translocation efficiency of EspH was reduced
such that it correlated with intracellular EspH concentration;
the significance of this observation is yet to be analyzed.
Translocation Autoinhibition
Two additional parameters that modulate translocation effi-
ciency are attachment and a putative autoinhibition process.
The former, which in EPEC is strongly affected by BFP, promotes
translocation by bringing the bacteria and host cell into closer
proximity. The latter, autoinhibition, was noted during this study,Celland its molecular basis is yet to be defined. The autoinhibition
phenomenanmight be an artifact of the in vitro system, not exist-
ing under relevant physiological conditions. Alternative specula-
tion is that one of the injected effectors, or the TTSS translocon
itself, somehow modifies the host cell membrane such that the
host cell is less competent for further translocation. The latter hy-
pothesis is very attractive because negative feedback loops are
common motifs in transcription and metabolic networks, func-
tioning as gauges to achieve stable steady state levels of net-
work components. It would be remarkable if EPEC uses the
same paradigm to achieve steady state levels for translocated
effector proteins in host cells. It is possible that this mechanism
evolved because it ensures that all host cells in the tissue contain
similar amounts of effector proteins. It could also prevent inject-
ing the host cells with an effector overdose that would kill them
too soon. Additional study is needed to confirm or discard the
translocation autoinhibition hypothesis.
EXPERIMENTAL PROCEDURES
Primers, Strains, and Plasmids
Primers, strains, and plasmids are listed in Tables S1, S2, and S3.
Plasmid Construction and Gene Inactivation
The plasmid pCX341was created by replacing the pCX340 origin of replication
with that of pBR322. The suicide plasmid pCX391 was derived from pGP704
by replacing the blaM gene with the tetRA cassette, taken from miniTn10,
and placing the rrnB T1 terminator, taken from pQE30, between TetR and
the pGP704 MCS. To create pME19, cesT was amplified and ligated into the
BamHI and HindIII sites of pQE30 containing lacIq. The cesF and cesT genes
were inactivated as described (Datsenko and Wanner, 2000). The primers
which were used for plasmid construction and gene inactivation are listed in
Table S1.
Creating Chromosomal effector-blaM Strains
The effector genes were amplified and ligated into pCX341 digested with
EcoRI and KpnI to create plasmids pCX392, pCX394, pCX395, pCX396,
pCX397, and pME21 (Table S3). These plasmids were digested with KpnI
and XbaI, and the resulting effector-blaM fragments were ligated into the
pCX391 digested with KpnI and XbaI. The resulting plasmids (pCX442,
pCX444, pCX445, pCX446, pCX447, and pME22, respectively) were propa-
gated in permissive strains (SY327lpir or MC1061lpir), and then transformed
into a conjugation competent permissive strain SM10lpir, which was then
crossed with EPEC strains. Transconjugants containing chromosomally inte-
grated plasmids were selected using LB-Tet-Strep agar plates (the parental
EPEC strain is streptomycin resistant). Proper integrations were verified by
PCR analysis and expression of the Effector-BlaM fusions was verified by
western blotting using monoclonal anti-BlaM antibodies (QED biosciences).
Real-Time Translocation Analysis
On day 1, HeLa cells were seeded in 96-well plates (black with clear bottom,
Greiner bio-one) at a density of23 104 cells/well in DMEM (Sigma) and sup-
plemented with 10% fetal calf serum (FCS) and antibiotics (Pen/Strep). In par-
allel, bacteria strains were inoculated and grown over night in LB broth, at
37C, as a static culture. On day 2, bacteria were diluted 1:100 into Casa-
mino-DMEM (CDMEM) (Berdichevsky et al., 2005) supplemented with 2.5 mM
probenecid (Sigma) and grown in conditions known to stimulate TTSS expres-
sion (37C, 5% CO2 for 2:45 hr to 0.2–0.35 OD600 nm), creating a preactivated
culture (Berdichevsky et al., 2005). An hour after starting the above bacterial
cultures, HeLa cells were washed twice with CDMEM and treated with 120
ml of CDMEM containing 20 ml of 63 CCF2/AM loading solution (CCF2/AM
loading kit, Invitrogen; 1 mM CCF2/AM and 2.5 mM probenecid final concen-
tration). The cells were incubated for 60 min in the dark at room temperature
and then for 15 min at 37C before being infected with 200 ml of bacterial cul-
tures. If needed, the bacterial concentration was adjusted before infection. InHost & Microbe 3, 104–113, February 2008 ª2008 Elsevier Inc. 111
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mM of b-lactamase inhibiting protein (BLIP). Immediately upon infection, the
plates were placed in a plate reader (SPECTRAFluor Plus, TECAN), set at
37C and thus the infection process took place in the plate reader. Cells
were excited at 405 nm, and emission at 465 nm and 535 nm was recorded
at 150 s intervals. Bacterial growth, OD at 600 nm, was also recorded. Data
were collected with Magelan5 Software and processed using the MATLAB
computing platform (as described in the Supplemental Data). The p values
were calculated as follows:
p= ½Praw  PBEK=½S0  SBEK
Praw, measured product fluorescence; PBEK, background fluorescence at 460
nm; S0, measured substrate fluorescence at t = 0; SBEK, background fluores-
cence at 530 nm. S0 normalizes the well-to-well variation in number of HeLa
cells and/or efficiency of CCF2 loading. Assays were carried out in duplicates
or triplicates. As a negative control we used wild-type EPEC (unmanipulated)
or wild-type EPEC containing pCX341.
Bacterial b-Lacatamase Activity Assay
Bacteria (10 ml) were grown as indicated, washed, resuspended in sonication
buffer (PBS, 1% Triton X-100, complete EDTA-free protease inhibitor, Roche),
and the OD was adjusted so that all samples analyzed would contain equiva-
lent numbers of bacteria. The different samples were sonicated and cleared by
centrifugation. The cleared sonicates were then mixed with the chromogenic
substrate nitrocefin (Calbiochem) to a final volume of 60 ml in a clear 96-well
plate and immediately placed in a plate reader (SPECTRAFluor Plus, TECAN)
and preset at 37C where the rate of color conversion from yellow (390 nm) to
red (486 nm) was recorded. Alternatively the CCF2/FA substrate was used
where indicated.
Extraction and Detection of Translocated Effector Proteins
Native effector proteins were extracted from infected HeLa cells and subjected
to immunoblot analysis as described (Tu et al., 2003).
Supplemental Data
The Supplemental Data include 11 supplemental figures and three supple-
mental tables and can be found with this article online at http://www.
cellhostandmicrobe.com/cgi/content/full/3/2/104/DC1/.
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